September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Human umbilical tissue-derived cells protect retinal pigment epithelial cells from oxidative damage
Author Affiliations & Notes
  • Sayak Kumar Mitter
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Michael E Boulton
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Ian Harris
    Janssen R&D, Spring House, Pennsylvania, United States
  • Jing Cao
    Janssen R&D, Spring House, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Sayak Mitter, Janssen R&D (F); Michael Boulton, Janssen R&D (F); Ian Harris, Janssen R&D (E); Jing Cao, Janssen R&D (E)
  • Footnotes
    Support  The work described was performed under a sponsored research agreement between Indiana University and Janssen R&D and a Research to Prevent Blindness Unrestricted Grant.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6031. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sayak Kumar Mitter, Michael E Boulton, Ian Harris, Jing Cao; Human umbilical tissue-derived cells protect retinal pigment epithelial cells from oxidative damage. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6031.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Retinal pigment epithelium (RPE) cells perform many functions crucial for retinal homeostasis and vision. RPE cell dysfunction results in various retinal degenerative diseases including age-related macular degeneration (AMD) for which there are currently no effective treatment. Cell therapies targeting RPE cells are being developed in the clinic for the treatment of retinal degeneration. Human umbilical tissue-derived cell (hUTC) is an allogeneic cell-based medicinal product for the treatment of geographic atrophy, an advanced form of dry AMD. We previously demonstrated that subretinal injection of hUTC preserves visual function and retinal architecture in the RCS rat with reduced apoptosis in the retina, suggesting that hUTC may have a protective effect on retina. The retina is particularly susceptible to oxidative stress and this plays an important role in the pathogenesis of AMD and contributes to RPE damage. Here, we aimed to determine whether hUTC could improve the health of RPE cells exposed to oxidative stress.

Methods : The ARPE-19 cell line was obtained from American Type Culture Collection. Primary human RPE (hRPE) cultures were prepared from postmortem human eyes obtained from donors and the purity was confirmed by cytokeratin staining. The MTT and crystal violet assays were performed to evaluate the cell viability of ARPE-19 and hRPE exposed to a lethal dose (1500 µM) of hydrogen peroxide (H2O2) after co-culturing with hUTC for 72 hours in transwell inserts. Western blots were preformed to examine the level of protein carbonylation, a key marker of oxidative stress induced damage, in ARPE-19 cells co-cultured with hUTC and then subject to sublethal doses of H2O2 (200 and 400 µM) for 3 and 6 hours, respectively.

Results : ARPE-19 co-cultured with hUTC for 72 hours showed significantly improved viability following treatment with 1500 µM H2O2 compared to untreated control cells, as assessed by both MTT and crystal violet assays. Similar results were obtained in hRPE. Moreover, a significantly lower level of protein carbonylation was observed in hUTC pretreated ARPE-19 cells exposed to 400 µM H2O2 for 6 hours as determined by Western blot analysis.

Conclusions : These findings suggest that hUTC may secrete factors that can potentially protect RPE from oxidative damage. Investigation is currently underway to examine the mechanisms of action.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.